IP Verse

Artificial Nucleic Acid Molecules For Improved Protein Expression - EP3708668

The patent EP3708668 was granted to Curevac on Jul 27, 2022. The application was originally filed on Dec 11, 2015 under application number EP20157801A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3708668

CUREVAC
Application Number
EP20157801A
Filing Date
Dec 11, 2015
Status
Granted And Under Opposition
Jun 24, 2022
Grant Date
Jul 27, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIONTECHApr 27, 2023HOPFNERADMISSIBLE
COOLEY UKApr 27, 2023CARPMAELS & RANSFORDADMISSIBLE
PFIZERApr 27, 2023EDERADMISSIBLE
SANOFIApr 27, 2023CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (37) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONEP2762165
OPPOSITIONEP3167059
OPPOSITIONEP3594337
OPPOSITIONUS2004110295
OPPOSITIONUS2009093433
OPPOSITIONWO0107590
OPPOSITIONWO02098443
OPPOSITIONWO2005075644
OPPOSITIONWO2007036366
OPPOSITIONWO2007068265
OPPOSITIONWO2008112127
OPPOSITIONWO2010037539
OPPOSITIONWO2011005799
OPPOSITIONWO2013090648
OPPOSITIONWO2013120628
OPPOSITIONWO2013120629
OPPOSITIONWO2013143698
OPPOSITIONWO2013143699
OPPOSITIONWO2013143700
OPPOSITIONWO2015101415
OPPOSITIONWO2016005324
OPPOSITIONWO2016091391
OPPOSITIONWO9914346
SEARCHEP3167059
SEARCHEP3594337
SEARCHWO0107590
SEARCHWO02098443
SEARCHWO2005075644
SEARCHWO2007036366
SEARCHWO2007068265
SEARCHWO2008112127
SEARCHWO2013120629
SEARCHWO2013143698
SEARCHWO2013143699
SEARCHWO2013143700
SEARCHWO2015101415
SEARCHWO2016005324

Non-Patent Literature (NPL) Citations (42) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "in vivo-jetPEI ®", Polyplus, (20240101), Polyplus, URL: https://www.polyplus-sartorius.com/products/in-vivo-jetpei#simple-2, XP093191461-
OPPOSITION- Anonymous, "Ovalbumin", (20230929), pages 1 - 3, Wikipedia , URL: https://en.wikipedia.org/w/index.php?title=Ovalbumin&oldid=1162529069, (20231107), XP093098786-
OPPOSITION- D91 - Order by the Court of Appeal of England and Wales-
OPPOSITION- D94 - Further declaration by from the University of Salzburg, Hellbrunnerstrasse 34, 5020 Salzburq, Austria-
OPPOSITION- DUBENSKY T. W., ET AL., "SINDBIS VIRUS DNA-BASED EXPRESSION VECTORS: UTILITY FOR IN VITRO AND IN VIVO GENE TRANSFER.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19960101), vol. 70., no. 01., ISSN 0022-538X, pages 508 - 519., XP002039561-
OPPOSITION- HERWEIJER H, ET AL., "A PLASMID-BASED SELF-AMPLIFYING SINDBIS VIRUS VECTOR", HUMAN GENE THERAPY, Mary Ann Liebert, Inc. Publishers, GB, GB , (19950901), vol. 06, no. 09, ISSN 1043-0342, pages 1161 - 1167, XP000789885-
OPPOSITION- "Homo sapiens RPL36AL mRNA for ribosomal protein L36a-like, complete cds.", EMBL, Database accession no. AB063609, URL: EBI, XP002699423-
OPPOSITION- James H. McCutchan, Joseph S. Pagano, "Enhancement of the Infectivity of Simian Virus 40 Deoxyribonucleic Acid With Diethylaminoethyl-Dextran", Journal of the National Cancer Institute, GB , (19680801), vol. 41, no. 2, doi:10.1093/jnci/41.2.351, ISSN 0027-8874, pages 351 - 357, XP009007119-
OPPOSITION- P L Felgner, Y Barenholz, J P Behr, S H Cheng, P Cullis, L Huang, J A Jessee, L Seymour, F Szoka, A R Thierry, E Wagner, G Wu, "Nomenclature for synthetic gene delivery systems", Hunan Gene Therapy, GB , (19970320), vol. 8, no. 5, doi:10.1089/hum.1997.8.5-511, ISSN 1043-0342, pages 511 - 512, XP001096052-
OPPOSITION- Riley Rachel S, Riley Rachel S, Kashyap Meghana V, Billingsley Margaret M, White Brandon, Alameh Mohamad-Gabriel, Bose Sourav K, Zoltick Philip W, Li Hiaying, Zhang Rui, Cheng Andrew Y, Weissman Drew, Peranteau William H, Mitchell Michael J, "Ionizable lipid nanoparticles for in utero mRNA delivery", Sci. Adv, (20210101), Sci. Adv, URL: https://www.science.org/doi/pdf/10.1126/sciadv.aba1028, (20220320), XP055903166-
OPPOSITION- T W Dubensky Jr , D A Driver, J M Polo, B A Belli, E M Latham, C E Ibanez, S Chada, D Brumm, T A Banks, S J Mento, D J Jolly, S M Chang, "Sindbis Virus DNA-Based Expression Vectors: Utility for In Vitro and In Vivo Gene Transfer", Journal of Virology, US , (19960101), vol. 70, no. 1, doi:10.1128/jvi.70.1.508-519.1996, ISSN 0022-538X, pages 508 - 519., XP002039561-
OPPOSITION- Sachs, A., "The role of poly(A) in the translation and stability of mRNA", Current Opinion in Cell Biology, Elsevier Current Trends, AMSTERDAM, NL, AMSTERDAM, NL , (19901201), vol. 2, no. 6, doi:10.1016/0955-0674(90)90161-7, ISSN 0955-0674, pages 1092 - 1098, XP023593425
OPPOSITION- Mockey, M. ; Goncalves, C. ; Dupuy, F.P. ; Lemoine, F.M. ; Pichon, C. ; Midoux, P., "mRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level", Biochemical and Biophysical Research Communications, Amsterdam NL , (20060224), vol. 340, no. 4, doi:10.1016/j.bbrc.2005.12.105, ISSN 0006-291X, pages 1062 - 1068, XP024924154
OPPOSITION- LEDDA M et al., "Effect of 3'UTR length on the translational regulation of 5'-terminal oligopyrimidine mRNAs", GENE, AMSTERDAM, NL, (20050103), vol. 344, doi:10.1016/j.gene.2004.09.023, pages 213 - 220, XP004712180
OPPOSITION- Nishat Sultana, Ajit Magadum, Yoav Hadas, Jason Kondrat, Neha Singh, Elias Youssef, Damelys Calderon, Elena Chepurko, Nicole Dubois, Roger J. Hajjar, Lior Zangi, "Optimizing Cardiac Delivery of Modified mRNA", Molecular Therapy, Elsevier Inc., US, US , (20170601), vol. 25, no. 6, doi:10.1016/j.ymthe.2017.03.016, ISSN 1525-0016, pages 1306 - 1315, XP055649234
OPPOSITION- "Oversized AAV Transductifon Is Mediated via a DNA-PKcs-independent, Rad51C-dependent Repair Pathwa", MOLECULAR THERAPY, (20131201), vol. 21, no. 12, doi:10.1038/mt.2013.184, pages 2205 - 2216, XP002797872
OPPOSITION- Sahin Ugur; Karikó Katalin; Türeci Özlem, "mRNA-based therapeutics — developing a new class of drugs", Nature Reviews Drug Discovery, GB , (20140919), vol. 13, no. 10, doi:10.1038/nrd4278, ISSN 1474-1776, pages 759 - 780, XP037134862
OPPOSITION- Sahin Ugur; Karikó Katalin; Türeci Özlem, "mRNA-based therapeutics — developing a new class of drugs", Nature Reviews Drug Discovery, Nature Publishing Group, GB, GB , (20140919), vol. 13, no. 10, doi:10.1038/nrd4278, ISSN 1474-1776, pages 759 - 780, XP037134862
OPPOSITION- POLO et al., "Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors", (19990400), vol. 96, doi:10.1073/pnas.96.8.4598, XP002139370
OPPOSITION- D. P. Diciommo, R. Bremner, "Rapid, High Level Protein Production Using DNA-based Semliki Forest Virus Vectors", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (19980717), vol. 273, no. 29, doi:10.1074/jbc.273.29.18060, ISSN 0021-9258, pages 18060 - 18066, XP055275933
OPPOSITION- Borman Andrew M., Michel Yanne M., Malnou Cécile E., Kean Katherine M., "Free Poly(A) Stimulates Capped mRNA Translation in Vitro through the eIF4G-Poly(A)-binding Protein Interaction", Journal of Biological Chemistry, US , (20020927), vol. 277, no. 39, doi:10.1074/jbc.M205065200, ISSN 0021-9258, pages 36818 - 36824, XP093088399
OPPOSITION- Mccarthy Sean D, Rohde Christopher B.; Angel Matt; Masterson Claire H.; Macloughlin Ronan; Fandiño Juan; González Héctor E.; Byrnes Declan; Laffey John G.; O'toole Daniel, "Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat", Nucleic Acid Therapeutics, Mary Ann Liebert, Inc. Publishers, US, US , (20230401), vol. 33, no. 2, doi:10.1089/nat.2022.0049, ISSN 2159-3337, pages 148 - 158, XP093170099
OPPOSITION- Masatomo et al., "Transcriptional termination and coupled polyadenylation in vitro", the EMBO Journal, (20001), vol. 19, doi:10.1093/emboj/19.14.3770, XP002974886
OPPOSITION- YONAHA M, PROUDFOOT N J, "Transcriptional termination and coupled polyadenylation in vitro", The EMBO journal / European Molecular Biology Organization, IRL Press, Oxford, Oxford , (20000101), vol. 19, no. 14, doi:10.1093/emboj/19.14.3770, ISSN 0261-4189, pages 3770 - 3777, XP002974886
OPPOSITION- GALLIE et al., "The histone 3'-terminal stem-loop is necessary for translation in Chinese hamster ovary cells", Nucleic Acids Research, (19960000), vol. 24, no. 10, doi:10.1093/nar/24.10.1954, XP002616165
OPPOSITION- Ferrari M. E., Rusalov Denis, Enas Joel, Wheeler Carl J, "Trends in lipoplex physical properties dependent on cationic lipid structure, vehicle and complexation procedure do not correlate with biological activity", Nucleic Acids research, Oxford University Press, GB, GB , (20010401), vol. 29, no. 7, doi:10.1093/nar/29.7.1539, ISSN 1362-4962, pages 1539 - 1548, XP093148217
OPPOSITION- T W Dubensky, "Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19960101), vol. 70, no. 1, doi:10.1128/jvi.70.1.508-519.1996, ISSN 0022-538X, pages 508 - 519, XP093159267
OPPOSITION- J N Zuckerman, "The importance of injecting vaccines into muscle", BMJ, (20001128), vol. 321, doi:10.1136/bmj.321.7271.1237, pages 1237 - 1238, XP055747296
OPPOSITION- Zuckerman, "The importance of injecting vaccines into muscle.", BMJ, (20001128), vol. 321, doi:10.1136/bmj.321.7271.1237, pages 1237 - 1238, XP055747296
OPPOSITION- S. HOLTKAMP et al., "Modification of antigen-encoding RNA increases stability, translational efficacy, and T- cell stimulatory capacity of dendritic cells", BLOOD, (20061215), vol. 108, no. 13, doi:10.1182/blood-2006-04-015024, pages 4009 - 4017, XP055044965
OPPOSITION- S. Holtkamp, S. Kreiter, A. Selmi, P. Simon, M. Koslowski, C. Huber, O. Tureci, U. Sahin, "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells", Blood, (20061215), vol. 108, no. 13, doi:10.1182/blood-2006-04-015024, ISSN 00064971, pages 4009 - 4017, XP055044965
OPPOSITION- Trepotec Zeljka; Geiger Johannes; Plank Christian; Aneja Manish K; Rudolph Carsten, "Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life", RNA, COLD SPRING HARBOR LABORATORY PRESS, US, US , (20190331), vol. 25, no. 4, doi:10.1261/rna.069286.118, ISSN 1355-8382, pages 507 - 518, XP009517039
OPPOSITION- V. Iadevaia, S. Caldarola, E. Tino, F. Amaldi, F. Loreni, "All translation elongation factors and the e, f, and h subunits of translation initiation factor 3 are encoded by 5'-terminal oligopyrimidine (TOP) mRNAs", RNA, Cambridge University Press on behalf of the RNA Society, (20080101), vol. 14, no. 9, doi:10.1261/rna.1037108, ISSN 13558382, pages 1730 - 1736, XP055044697
OPPOSITION- Milone Joseph, Wilusz Jeffrey, Bellofatto Vivian, "Characterization of deadenylation in trypanosome extracts and its inhibition by poly(A)-binding protein Pab1p", RNA, COLD SPRING HARBOR LABORATORY PRESS, US, US , (20040101), vol. 10, doi:10.1261/rna.5180304, ISSN 1355-8382, pages 448 - 457, XP093088409
OPPOSITION- Milone Joseph, Wilusz Jeffrey, Bellofatto Vivian, "Characterization of deadenylation in trypanosome extracts and its inhibition by poly(A)-binding protein Pab1p", RNA, US , (20040101), vol. 10, doi:10.1261/rna.5180304, ISSN 1355-8382, pages 448 - 457, XP093088409
OPPOSITION- Firdessa-Fite Rebuma, Postigo-Fernandez Jorge, Toussaint-Moreau Valérie, Stock Fabrice, Nyamay’antu Alengo, Erbacher Patrick, Creusot Rémi J, "Promising non-viral vector for efficient and versatile delivery of mRNA for antigen-specific immunotherapy", Cell and Gene Therapy Insights, (20201029), vol. 6, no. 9, doi:10.18609/cgti.2020.154, ISSN 2059-7800, pages 1399 - 1409, XP093020997
OPPOSITION- Andreani Julien, Khalil Jacques Y. B., Baptiste Emeline, Hasni Issam, Michelle Caroline, Raoult Didier, Levasseur Anthony, La Scola Bernard, "Orpheovirus IHUMI-LCC2: A New Virus among the Giant Viruses", Frontiers in Microbiology, Frontiers Media, Lausanne, Lausanne , vol. 8, doi:10.3389/fmicb.2017.02643, ISSN 1664-302X, XP093148218
OPPOSITION- Thomas Schlake, Andreas Thess, Mariola Fotin-Mleczek, Karl-Josef Kallen, "Developing mRNA-vaccine technologies", RNA BIOLOGY, (20121101), vol. 9, no. 11, doi:10.4161/rna.22269, ISSN 1547-6286, pages 1319 - 1330, XP055561756
OPPOSITION- Khanam Tasneem, Muddashetty Ravi Sondekoppa, Kahvejian Avak, Sonenberg Nahum, Brosius Juergen, "Poly(A)-Binding Protein Binds to A-Rich Sequences via RNA-Binding Domains 1+2 and 3+4", RNA BIOLOGY, (20060101), vol. 3, no. 4, doi:10.4161/rna.3.4.4075, ISSN 1547-6286, pages 170 - 177, XP093088415
SEARCH- "Homo sapiens RPL36AL mRNA for ribosomal protein L36a-like, complete cds", EMBL, (20021002), XP002699423 [A] 1-32 * abstract *-
SEARCH- LEDDA M ET AL, "Effect of 3'UTR length on the translational regulation of 5'-terminal oligopyrimidine mRNAs", GENE, ELSEVIER, AMSTERDAM, NL, vol. 344, ISSN 0378-1119, (20050103), pages 213 - 220, (20050103), XP027872598 [A] 1-32 * the whole document *-
SEARCH- S. HOLTKAMP ET AL, "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells", BLOOD, (20061215), vol. 108, no. 13, doi:10.1182/blood-2006-04-015024, ISSN 0006-4971, pages 4009 - 4017, XP055044965 [A] 1-32 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents